Osimertinib
From Proteopedia
| ||||||||||||
Osimertinib, sold under the brand name Tagrisso,[1] is a medication used to treat non-small-cell lung carcinomas with specific mutations.[2][3][5][6] It is a third-generation epidermal growth factor receptor tyrosine kinase inhibitor.
| ||||||||||||
This page was last modified 11:00, 9 October 2023.